We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| One Health Group PLC | AQSE:OHGR | Aquis Stock Exchange | Ordinary Share | GB00BNNT0595 | Ordinary shares |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 210.00 | 190.00 | 240.00 | 215.00 | 205.00 | 210.00 | 0.00 | 15:29:03 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Dec 2022 to Dec 2024
TIDMOHGR
RNS Number : 2219M
One Health Group PLC
13 September 2023
One Health Group PLC
PDMR Share Dealing
TR1
13 September 2023
One Health Group PLC ("One Health" or the "Company") announces the following dealings in its shares by Jessica Sellars, who is a person discharging managerial responsibilities in the Company, and by One Health Group Trustees LLP, which is the trustee of the Company's Employee Benefit Trust and a person closely associated with Derek Bickerstaff and Adam Binns and who are directors of the Company, in each case, pursuant to and subsequent to the exercise of options granted under the One Health Group Limited EMI Share Option Plan ("EMI Options), on 11 September 2023:
-- Jessica Sellars exercised EMI Options to purchase 50,000 shares in the Company at a price of 66.7 pence per share and sold 50,000 shares in the Company at a price of 162.5 pence per share;
-- One Health Group Trustees LLP sold 50,000 shares in the Company at a price of 66.7 pence per share and acquired 50,000 shares in the Company at a price of 162.5 pence per share.
Further details of the disclosures made to the Company by Jessica Sellars and One Health Group Trustees LLP are contained in Appendix 1.
Following the above dealings, there is no change to the shareholding of Jessica Sellars in the Company.
Appendix 2 contains disclosure forms relating to One Health Group Trustees LLP which has notified One Health that it controlled over 3% of the Total Voting Rights in the Company and that its percentage interest has changed as a result of its sale and acquisition of shares in the Company outlined above. Following these dealings, One Health Group Trustees LLP will hold 977,066 shares in the Company, representing approximately 9.30% of the Company's issued share capital.
This announcement contains inside information for the purposes of Article 7 of EU Regulation
596/2014. Which is part of the United Kingdom domestic law pursuant to the Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)("UK MAR").
The directors of One Health accept responsibility for this announcement.
Enquiries
One Health Group PLC Via Square 1 Consulting Oberon Capital (AQSE Corporate Adviser and Broker) Nick Lovering, Mike Seabrook 020 3179 5300 Square 1 Consulting David Bick 020 7929 5599
Appendix 1
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
Hot Features
Premium
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Jessica Clare Sellars
2. Reason for the notification
a) Position/status: Director of Operations and Service
Development
b Initial notification/Amendment: Initial notification
--------------------------------- ------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name: One Health Group PLC
b) LEI: 984500DC689F5BAD8732
------- ----------------------
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the financial Ordinary shares of GBP0.005 each
instrument, type of instrument:
ISIN Code: GB00BNNT0595
Identification code:
b) Nature of the transaction: Purchase of share pursuant to the
exercise of options; and
Sale of shares
---------------------------------- -----------------------------------
c) Price(s) and Volume (s): Purchase price(s). 66.7p
Volume(s): 50 ,000
Sale price(s). 162.5p
Volume(s): 50,000
---------------------------------- -----------------------------------
d) Aggregated Information: N/A
Aggregated volume:
Price:
---------------------------------- -----------------------------------
e) Date of the transaction: 11 September 2023
---------------------------------- -----------------------------------
f) Place of the transaction Aquis (AQSE)
---------------------------------- -----------------------------------
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: One Health Group Trustees LLP
2. Reason for the notification
a) Position/status: Corporate Trustee of EBT
b Initial notification/Amendment: Initial notification
--------------------------------- --------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name: One Health Group PLC
b) LEI: 984500DC689F5BAD8732
------- ----------------------
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the financial Ordinary shares of GBP0.005 each
instrument, type of instrument:
ISIN Code: GB00BNNT0595
Identification code:
b) Nature of the transaction: Sale of shares and
Purchase of shares
---------------------------------- ----------------------------------
c) Price(s) and Volume (s): Sale price(s). 66.7p
Volume(s): 50,000
Purchase price(s). 162.5p
Volume(s): 50,000
---------------------------------- ----------------------------------
d) Aggregated Information: N/A
Aggregated volume:
Price:
---------------------------------- ----------------------------------
e) Date of the transaction: 11 September 2023
---------------------------------- ----------------------------------
f) Place of the transaction Aquis (AQSE)
---------------------------------- ----------------------------------
Appendix 2
Disclosure forms re major share holdings
TR-1: standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and
to the FCA in Microsoft Word format if possible) (i)
1a. Identity of the issuer or the ONE HEALTH GROUP PLC
underlying issuer of existing shares 131 Psalter Lane Sheffield S11 8UX
to which voting rights are attached LEI: 984500DC689F5BAD8732
(ii) :
--------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
Non-UK issuer
----
2. Reason for the notification (please mark the appropriate box or boxes
with an "X")
An acquisition or disposal of voting rights X
----
An acquisition or disposal of financial instruments
----
An event changing the breakdown of voting rights
----
Other (please specify) (iii) :
----
3. Details of person subject to the notification obligation (iv)
Name One Health Group Trustees LLP
City and country of registered office Sheffield, South Yorkshire, England
(if applicable)
4. Full name of shareholder(s) (if different from 3.) (v)
Name As above
--------------------------------------------
City and country of registered office
(if applicable)
--------------------------------------------
5. Date on which the threshold was 11(th) September 2023
crossed or reached (vi) :
--------------------------------------------
6. Date on which issuer notified 11(th) September 2023
(DD/MM/YYYY):
--------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights Total of both Total number
rights attached through financial in % (8.A + of voting rights
to shares (total instruments 8.B) held in issuer
of 8. A) (total of 8.B (8.A + 8.B)
1 + 8.B 2) (vii)
------------------ --------------------- -------------- --------------------
Resulting situation
on the date
on which threshold
was crossed
or reached 8.82% 8.82% 927,066
------------------ --------------------- -------------- --------------------
Position of
previous notification
(if
applicable) 9.30% 9.30%
------------------ --------------------- -------------- --------------------
8. Notified details of the resulting situation on the date on which
the threshold was crossed or reached (viii)
A: Voting rights attached to shares
Class/type of Number of voting rights % of voting rights
shares (ix)
ISIN code (if
possible)
Direct Indirect Direct Indirect
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
---------------------
GB00BNNT0595 927,066 8.82%
--------------------- --------------------- -------------------- ----------------
SUBTOTAL 8.
A 927,066 8.82%
-------------------------------------------- --------------------------------------
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion Period rights that may rights
(x) (xi) be acquired if
the instrument
is
exercised/converted.
----------- ------------------------- -------------------------- ----------------
SUBTOTAL 8. B
1
------------------------- -------------------------- ----------------
B 2: Financial Instruments with similar economic effect according to
DTR5.3.1R (1) (b)
Type of financial Expiration Exercise/ Physical Number of % of voting
instrument date (x) Conversion or cash voting rights rights
Period (xi) Settlement
(xii)
---------------- ---------------- ----------------- ----------------
SUBTOTAL
8.B.2
----------------- ----------------
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled x
by any natural person or legal entity and does not control any other
undertaking(s) holding directly or indirectly an interest in the
(underlying) issuer (xiii)
Full chain of controlled undertakings through which the voting rights
and/or the
financial instruments are effectively held starting with the ultimate
controlling natural person or legal entity (please add additional
rows as necessary) (xiv)
Name (xv) % of voting rights % of voting rights Total of both if
if it equals or through financial it equals or is
is higher than the instruments if it higher than the
notifiable threshold equals or is higher notifiable threshold
than the notifiable
threshold
---------------------- --------------------- ------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder
-----------------------------------------------
The number and % of voting rights
held
-----------------------------------------------
The date until which the voting rights
will be held
-----------------------------------------------
11. Additional information (xvi)
Place of completion Aquis (AQSE)
Date of completion 11 September 2023
------------------
TR-1: standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and
to the FCA in Microsoft Word format if possible) (i)
1a. Identity of the issuer or the ONE HEALTH GROUP PLC
underlying issuer of existing shares 131 Psalter Lane Sheffield S11 8UX
to which voting rights are attached LEI: 984500DC689F5BAD8732
(ii) :
--------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
Non-UK issuer
----
2. Reason for the notification (please mark the appropriate box or boxes
with an "X")
An acquisition or disposal of voting rights X
----
An acquisition or disposal of financial instruments
----
An event changing the breakdown of voting rights
----
Other (please specify) (iii) :
----
3. Details of person subject to the notification obligation (iv)
Name One Health Group Trustees LLP
City and country of registered office Sheffield, South Yorkshire, England
(if applicable)
4. Full name of shareholder(s) (if different from 3.) (v)
Name As above
--------------------------------------------
City and country of registered office
(if applicable)
--------------------------------------------
5. Date on which the threshold was 11(th) September 2023
crossed or reached (vi) :
--------------------------------------------
6. Date on which issuer notified 11(th) September 2023
(DD/MM/YYYY):
--------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights Total of both Total number
rights attached through financial in % (8.A + of voting rights
to shares (total instruments 8.B) held in issuer
of 8. A) (total of 8.B (8.A + 8.B)
1 + 8.B 2) (vii)
------------------ --------------------- -------------- --------------------
Resulting situation
on the date
on which threshold
was crossed
or reached 9.30% 9.30% 977,066
------------------ --------------------- -------------- --------------------
Position of
previous notification
(if
applicable) 8.82% 8.82%
------------------ --------------------- -------------- --------------------
8. Notified details of the resulting situation on the date on which
the threshold was crossed or reached (viii)
A: Voting rights attached to shares
Class/type of Number of voting rights % of voting rights
shares (ix)
ISIN code (if
possible)
Direct Indirect Direct Indirect
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
---------------------
GB00BNNT0595 977,066 9.30%
--------------------- --------------------- -------------------- ----------------
SUBTOTAL 8.
A 977,066 9.30%
-------------------------------------------- --------------------------------------
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion Period rights that may rights
(x) (xi) be acquired if
the instrument
is
exercised/converted.
----------- ------------------------- -------------------------- ----------------
SUBTOTAL 8. B
1
------------------------- -------------------------- ----------------
B 2: Financial Instruments with similar economic effect according to
DTR5.3.1R (1) (b)
Type of financial Expiration Exercise/ Physical Number of % of voting
instrument date (x) Conversion or cash voting rights rights
Period (xi) Settlement
(xii)
---------------- ---------------- ----------------- ----------------
SUBTOTAL
8.B.2
----------------- ----------------
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled x
by any natural person or legal entity and does not control any other
undertaking(s) holding directly or indirectly an interest in the
(underlying) issuer (xiii)
Full chain of controlled undertakings through which the voting rights
and/or the
financial instruments are effectively held starting with the ultimate
controlling natural person or legal entity (please add additional
rows as necessary) (xiv)
Name (xv) % of voting rights % of voting rights Total of both if
if it equals or through financial it equals or is
is higher than the instruments if it higher than the
notifiable threshold equals or is higher notifiable threshold
than the notifiable
threshold
---------------------- --------------------- ------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder
-----------------------------------------------
The number and % of voting rights
held
-----------------------------------------------
The date until which the voting rights
will be held
-----------------------------------------------
11. Additional information (xvi)
Place of completion Aquis (AQSE)
Date of completion 11 September 2023
------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NEXDZGMLVZNGFZM
(END) Dow Jones Newswires
September 13, 2023 02:00 ET (06:00 GMT)
1 Year One Health Chart |
1 Month One Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
